What Are the Reliable Plasma Biomarkers for Mild Cognitive Impairment? A Clinical 4D Proteomics Study and Validation

• 主要な著者: Zhitao Hou (著者), Ailin Sun (著者), Yan Li (著者), Xiaochen Song (著者), Shu Liu (著者), Xinying Hu (著者), Yihan Luan (著者), Huibo Guan (著者), Changyuan He (著者), Yuefeng Sun (著者), Jing Chen (著者)
• フォーマット: 図書
• 出版事項: Hindawi Limited, 2024-01-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Objective. At present, Alzheimer's disease (AD) lacks effective treatment means, and early diagnosis and intervention are the keys to treatment. Therefore, for mild cognitive impairment (MCI) and AD patients, blood sample analysis using the 4D nonstandard (label-free) proteomic in-depth quantit...